Cargando…
Imbalance in the blood antioxidant system in growth hormone-deficient children before and after 1 year of recombinant growth hormone therapy
The aim of our study was to examine the effects of 12-month therapy with recombinant growth hormone (rGH) on the blood antioxidant system in children with growth hormone deficiency (GHD). Total antioxidant capacity (TAC) of plasma was measured by FRAP (ferric reducing antioxidant power or ferric red...
Autores principales: | Pankratova, Maria S., Baizhumanov, Adil A., Yusipovich, Alexander I., Faassen, Maria, Shiryaeva, Tatyana Yu., Peterkova, Valentina A., Kovalenko, Svetlana S., Kazakova, Tatiana A., Maksimov, Georgy V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485705/ https://www.ncbi.nlm.nih.gov/pubmed/26137433 http://dx.doi.org/10.7717/peerj.1055 |
Ejemplares similares
-
Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency
por: Alzahrani, Ali K, et al.
Publicado: (2020) -
In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
por: Bugalho, Maria João, et al.
Publicado: (2023) -
OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial
por: Thornton, Paul, et al.
Publicado: (2019) -
Attenuation of Human Growth Hormone-Induced Rash With Graded Dose Challenge
por: Mann, Jake, et al.
Publicado: (2022) -
PSUN314 Severe Insulin Resistance Impacts the Growth Hormone-Insulin-Like Growth Factor-I Axis and Linear Growth
por: Okawa, Marinna
Publicado: (2022)